Macquarie Group
WVE icon

Macquarie Group’s Wave Life Sciences WVE Stock Holding History

Macquarie Group’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-81,955
Closed -$600K – 1524
2025
Q3 		$600K Sell
81,955
-184,901
-69% -$1.5M ﹤0.01% 1398
2025
Q2 		$1.74M Sell
266,856
-5,470
-2% -$36.1K ﹤0.01% 1263
2025
Q1 		$2.2M Buy
272,326
+38,645
+17% +$423K ﹤0.01% 1189
2024
Q4 		$2.89M Buy
233,681
+151,726
+185% +$2.03M ﹤0.01% 1079
2024
Q3 		$672K Hold
81,955
– – ﹤0.01% 1437
2024
Q2 		$409K Hold
81,955
– – ﹤0.01% 1490
2024
Q1 		$506K Hold
81,955
– – ﹤0.01% 1448
2023
Q4 		$414K Hold
81,955
– – ﹤0.01% 1492
2023
Q3 		$471K Hold
81,955
– – ﹤0.01% 1446
2023
Q2 		$298K Hold
81,955
– – ﹤0.01% 1515
2023
Q1 		$355K Hold
81,955
– – ﹤0.01% 1502
2022
Q4 		$574K Hold
81,955
– – ﹤0.01% 1495
2022
Q3 		$296K Hold
81,955
– – ﹤0.01% 1581
2022
Q2 		$266K Hold
81,955
– – ﹤0.01% 1670
2022
Q1 		$164K Hold
81,955
– – ﹤0.01% 1842
2021
Q4 		$257K Hold
81,955
– – ﹤0.01% 1723
2021
Q3 		$402K Hold
81,955
– – ﹤0.01% 1704
2021
Q2 		$546K Hold
81,955
– – ﹤0.01% 1685
2021
Q1 		$460K Buy
+81,955
New +$787K ﹤0.01% 1549

Other funds holding WVE

GP
GSK plc London $602M AUM
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return

Macquarie Group's WVE Position: Q4 2025 in Review

Macquarie Group sold out of Wave Life Sciences (WVE) in Q4 2025, closing a stake of 81,955 shares — an estimated $600K sold.

Macquarie Group first reported a position in WVE in Q1 2021 and held it in 19 quarters. The position peaked at $2.89M in Q4 2024. 218 funds tracked by Wall St. Rank hold WVE as of Q4 2025.

  • Macquarie Group reported no remaining Wave Life Sciences position as of Q4 2025 after selling out during the quarter.
  • Macquarie Group sold 81,955 Wave Life Sciences shares in Q4 2025, an estimated $600K.
  • Macquarie Group first reported a position in Wave Life Sciences in Q1 2021 and held it in 19 quarters.
  • Macquarie Group's Wave Life Sciences position peaked at $2.89M in Q4 2024.
  • 218 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2025.

Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.